HOB Biotech GroupLtd Balance Sheet Health
Financial Health criteria checks 6/6
HOB Biotech GroupLtd has a total shareholder equity of CN¥818.1M and total debt of CN¥83.7M, which brings its debt-to-equity ratio to 10.2%. Its total assets and total liabilities are CN¥978.0M and CN¥159.9M respectively. HOB Biotech GroupLtd's EBIT is CN¥52.1M making its interest coverage ratio 272.5. It has cash and short-term investments of CN¥118.4M.
Key information
10.2%
Debt to equity ratio
CN¥83.66m
Debt
| Interest coverage ratio | 272.5x |
| Cash | CN¥118.37m |
| Equity | CN¥818.07m |
| Total liabilities | CN¥159.93m |
| Total assets | CN¥977.99m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688656's short term assets (CN¥285.4M) exceed its short term liabilities (CN¥157.6M).
Long Term Liabilities: 688656's short term assets (CN¥285.4M) exceed its long term liabilities (CN¥2.3M).
Debt to Equity History and Analysis
Debt Level: 688656 has more cash than its total debt.
Reducing Debt: 688656's debt to equity ratio has reduced from 19.4% to 10.2% over the past 5 years.
Debt Coverage: 688656's debt is well covered by operating cash flow (129.4%).
Interest Coverage: 688656's interest payments on its debt are well covered by EBIT (272.5x coverage).